REG - Convatec Group PLC - Results of AGM

ConvaTecAnnouncement

Today 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260521:nRSU3371Fa&default-theme=true

RNS Number : 3371F  Convatec Group PLC  21 May 2026

21 May 2026

Convatec Group Plc

(Convatec or the Company)

 

Results of the Annual General Meeting

 

Convatec's Annual General Meeting (AGM) was held at 20 Eastbourne Terrace,
Paddington, London, W2 6LG on Thursday, 21 May 2026 at 14:00.

 

All resolutions set out in the Notice of Meeting were duly passed by way of a
poll.  The results are set out below:

 

                                                        For(1)                                Against(1)                             Votes total                   % of ISC voted(3)  Withheld(2)

(excluding withheld(2))
 Resolution                                             No of shares                  %       No of shares                   %
 1       2025 Annual Reports and Accounts                       1,583,600,321         97.97%            32,856,766           2.03%           1,616,457,087         82.69%                            5,973,533
 2       Remuneration Report                                    1,057,723,791         65.77%          550,589,931            34.23%          1,608,313,722         82.27%                          14,116,898
 3       Dividend                                               1,584,518,305         97.96%            32,961,425           2.04%           1,617,479,730         82.74%                            4,950,890
 4       Elect Fiona Ryder                                      1,578,260,187         97.58%            39,097,452           2.42%           1,617,357,639         82.74%                            5,072,981
 5       Re-elect Dr John McAdam                                1,546,263,951         95.60%            71,094,592           4.40%           1,617,358,543         82.74%                            5,072,077
 6       Re-elect Jonny Mason                                   1,580,750,694         97.73%            36,713,081           2.27%           1,617,463,775         82.74%                            4,966,845
 7       Re-elect Margaret Ewing                                1,568,485,590         96.98%            48,871,739           3.02%           1,617,357,329         82.74%                            5,073,291
 8       Re-elect Brian May                                     1,534,104,114         94.85%            83,252,311           5.15%           1,617,356,425         82.74%                            5,074,195
 9       Re-elect Professor Constantin Coussios(4)      WITHDRAWN
 10      Re-elect Kim Lody                                      1,566,266,564         96.84%            51,089,725           3.16%           1,617,356,289         82.74%                            5,074,331
 11      Re-elect Heather Mason                                 1,570,362,017         97.09%            46,995,312           2.91%           1,617,357,329         82.74%                            5,073,291
 12      Re-elect Sharon O'Keefe                                1,565,589,732         96.80%            51,764,294           3.20%           1,617,354,026         82.74%                            5,076,594
 13      Appoint Ernst & Young LLP as auditors                  1,584,246,288         97.95%            33,122,017           2.05%           1,617,368,305         82.74%                            5,062,315
 14      Auditors' remuneration                                 1,584,397,363         97.96%            32,969,022           2.04%           1,617,366,385         82.74%                            5,064,235
 15      Political donations                                    1,526,399,577         94.09%            95,877,488           5.91%           1,622,277,065         82.99%                               153,555
 16      Allotment of shares                                    1,399,668,923         86.54%          217,704,840            13.46%          1,617,373,763         82.74%                            5,056,857
 17      Disapplication of pre-emption rights*                  1,509,552,149         93.33%          107,800,388            6.67%           1,617,352,537         82.74%                            5,078,083
 18      Further disapplication of pre-emption rights*          1,403,547,455         86.78%          213,807,368            13.22%          1,617,354,823         82.74%                            5,075,797
 19      Purchase of own shares*                                1,583,783,948         97.95%            33,142,423           2.05%           1,616,926,371         82.71%                            5,504,249
 20      Notice for General Meetings*                           1,466,844,869         90.69%          150,521,910            9.31%           1,617,366,779         82.74%                            5,063,841

 

Notes to the disclosure:

*Special Resolution.

1.     Votes "For" and "Against" are expressed as a percentage of votes
received.

2.     A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

3.     Total number of shares in issue is 1,954,852,029 (82.99% of capital
was voted).

4.     As announced on 13 April 2026, Professor Constantin Coussios
stepped down from his role as Non-executive Director of the Company on 30
April 2026. Accordingly, the resolution to re-elect Professor Constantin
Coussios as a director of the Company (resolution 9 in the Notice of Meeting)
was withdrawn.

5.     Computershare acted as scrutineer of the poll on all resolutions.

 

The Board is pleased that all resolutions were supported at today's AGM.
We recognise the vote for Resolution 2 (Remuneration Report) was below 80%.
We will continue to engage with and listen to the views of shareholders and
the proxy advisers on remuneration matters, building on the engagement
carried out with c. 85% of our shareholders prior to the meeting. An update
on that engagement, and on any action taken as a result of these votes, will
be published within six months of the AGM in accordance with the UK
Corporate Governance Code, with a final summary to be included in the
Company's 2026 Annual Report.

 

In accordance with UKLR 6.4.2, copies of the resolutions that do not
constitute ordinary business that were passed at the Annual General Meeting
have been submitted to the National Storage Mechanism and will be available
for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

Enquiries

 

James Kerton

Company Secretary

Email: cosec@convatec.com (mailto:cosec@convatec.com)

 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

 

Classification: 3.1 Additional regulated information required to be disclosed
under the laws of the United Kingdom

 

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in Advanced
Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than
10,000 colleagues, we provide products and services in around 90 countries,
united by a promise to be forever caring. Our solutions provide a range of
benefits, from infection prevention, treatment for hard to heal wounds,
at-risk skin and ulcerated tissue to supporting debilitating conditions,
improved patient outcomes and reduced care costs. Convatec's revenues in 2025
were over $2 billion. The company is a constituent of the FTSE 100 Index
(LSE:CTEC). To learn more please visit http://www.convatecgroup.com
(https://www.convatecgroup.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGAKDBBQBKDPPB



            Copyright 2019 Regulatory News Service, all rights reserved